Search clinical trials for: KAI-1678
Total 1207 results
-
KAI PharmaceuticalsTrident Clinical Research Pty LtdCompletedSpinal Cord InjuryAustralia
-
Kai Medical, Inc.Unknown
-
Kai Medical, Inc.CompletedSnoring | Sleep ApneaUnited States
-
RemeGen Co., Ltd.Completed
-
NorWest Co-op Community HealthWithdrawn
-
KAI PharmaceuticalsBristol-Myers Squibb; The Cleveland Clinic; Duke UniversityCompletedMyocardial Infarction | Pathologic Processes | Cardiovascular DiseasesPoland, Germany, Spain, Belgium, Israel, United States, Australia, Netherlands, Finland, Sweden, Canada, New Zealand, Czech Republic, Hungary, Italy, Denmark, Portugal, Norway
-
KAI PharmaceuticalsCompletedMyocardial InfarctionUnited States
-
Northeast Normal UniversityRecruiting
-
KAI PharmaceuticalsTrident Clinical Research Pty LtdCompletedPain, PostoperativeNew Zealand
-
KAI PharmaceuticalsTrident Clinical Research Pty LtdCompletedPostherpetic NeuralgiaAustralia
-
Institute for Neurodegenerative DisordersTerminatedAlzheimer's DiseaseUnited States
-
KAI PharmaceuticalsNucleus Network LtdCompletedHyperparathyroidism, SecondaryAustralia
-
Shenzhen TargetRx, Inc.M.D. Anderson Cancer CenterNot yet recruitingChronic Myelogenous LeukemiaUnited States
-
Newave Pharmaceutical IncRecruitingFollicular Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Hairy Cell Leukemia | CLL/SLLUnited States
-
Guangzhou Lupeng Pharmaceutical Company LTD.Recruiting
-
Cerebos Pacific LimitedUnknown
-
Shenzhen TargetRx, Inc.Peking University People's HospitalRecruitingChronic Myelogenous LeukemiaChina
-
ModernaTX, Inc.Active, not recruiting
-
AmgenCompleted
-
KAI PharmaceuticalsCompletedHyperparathyroidism, SecondaryUnited States, Australia
-
Guangzhou Lupeng Pharmaceutical Company LTD.Completed
-
Selayang HospitalCompletedAcute Kidney Injury | Acute Renal Failure | Kidney Failure, Acute | Hospital Acquired ConditionMalaysia
-
Guangzhou Lupeng Pharmaceutical Company LTD.Completed
-
AltruBio Inc.CompletedSteroid-refractory Acute Graft-versus-Host Disease | Treatment-refractory Acute Graft-versus-Host DiseaseUnited States
-
Guangzhou Lupeng Pharmaceutical Company LTD.RecruitingMantle Cell Lymphoma (MCL)China
-
University Health Network, TorontoStryker EndoscopyRecruitingObesity, Morbid | Ulcer, GastricCanada
-
KAI PharmaceuticalsCompletedSecondary HyperparathyroidismUnited States
-
Lidian ChenPeking University Third HospitalNot yet recruiting
-
Moon (Guangzhou) Biotechnology Co., Ltd.Not yet recruitingAdvanced Malignant Solid Tumors
-
Guangzhou Lupeng Pharmaceutical Company LTD.Completed
-
Harvard University Faculty of MedicineBeth Israel Deaconess Medical Center; Brigham and Women's HospitalCompleted
-
Zhongda HospitalCompleted
-
NewG Lab PharmaActive, not recruitingHepatocellular Carcinoma | Fibrolamellar CarcinomaKorea, Republic of
-
National Cancer Center, ChinaNot yet recruiting
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States, Belgium, Italy, United Kingdom, Canada, Germany, Spain, Austria, Czechia, Hungary, France, Israel, Poland, Australia, Russian Federation
-
TCI Co., Ltd.Completed
-
Chengdu University of Traditional Chinese MedicineUnknown
-
AltruBio Inc.TerminatedUlcerative ColitisUnited States, Puerto Rico
-
KAI PharmaceuticalsCompleted
-
Mayo ClinicCompletedAcute Kidney InjuryUnited States
-
University Hospital, Clermont-FerrandCompleted
-
University of ManitobaNorWest Co-op Community HealthRecruitingMental Health | Loneliness | Health-Related Behavior | Social IsolationCanada
-
Guy's and St Thomas' NHS Foundation TrustKing's College LondonActive, not recruiting
-
Meyer Children's Hospital IRCCSUniversity of FlorenceRecruiting
-
Taipei Veterans General Hospital, TaiwanNational Science Council, TaiwanCompleted
-
Ohio UniversityCompletedCardiovascular Diseases | Hypertension | Diabetes | Dyslipidemias | Overweight and ObesityUnited States
-
Kala Pharmaceuticals, Inc.CompletedOcular Infections, Irritations and InflammationsUnited States
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States
-
ABM Therapeutics CorporationRecruitingAdvanced Solid Tumor | RAS Mutation | NF1 Mutation | RAF MutationUnited States